March, 2024
March 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
U.S. FDA summarizes their decision to restrict the approval of olaparib + abiraterone – American Society of Clinical Oncology (ASCO)
Dec 29, 2023, 05:18

U.S. FDA summarizes their decision to restrict the approval of olaparib + abiraterone – American Society of Clinical Oncology (ASCO)

American Society of Clinical Oncology (ASCO) shared on their X/Twitter page:

Breaking from Journal of Clinical Oncology: U.S. FDA summarizes their decision to restrict the approval of olaparib + abiraterone to patients with BRCA-mutated mCRPC rather than grant approval for all patients. Read in ASCO Daily News.”

Source: American Society of Clinical Oncology/X